We use Google Analytics to see which pages are read and how the site is used, so we know what to improve. This only runs if you accept. See our privacy notice for details.

Dáil

Written answer

Medicinal Products

1002. Deputy Colm Burke asked the Minister for Health given that a medication (details supplied) has been made available to eligible patients through the publicly funded healthcare system in Northern Ireland, whether she is concerned that eligible patients with pulmonary arterial hypertension in Ireland continue to await a reimbursement decision; the reason the application, recorded by the HSE as 'Proposal from Applicant Under Review' since 16 June 2026, has not yet progressed to consideration by the HSE Drugs Group; and the timeframe applications will be considered by the drugs group. [79644/26]

Comment on this